
Pharmaceutical Battle: Novo Nordisk, Eli Lilly, Pfizer and AstraZeneca in the Race.
Pharmaceutical Battle: Novo Nordisk, Eli Lilly, Pfizer and AstraZeneca in the Race.
403 articles on leadership, communication and professional development.

Pharmaceutical Battle: Novo Nordisk, Eli Lilly, Pfizer and AstraZeneca in the Race.

Merck Acquires Caraway Therapeutics for up to 610 Million Dollars

Bayer Invests 130 Million in New Plant in Berlin

Roche Buys Telavant for 6.7 Billion Euros

Amazon Offers Virtual Medical Consultations to Prime Customers

This is your brain on air pollution

MSD Addresses Urgency of Early Cancer Detection

Sanofi drives fight against Diabetes with innovative technology.

J&J Seeks Approval for Surgical Robot Trials

Roche will invest $240 million in 5 years.

Abbott loses 11% on stock market due to FDA warnings.

AbbVie and Pfizer: Decline in Their Flagship Products

Novo Nordisk seeks alliances against obesity and diabetes.

Eli Lilly obtains approval in Europe to treat Lymphoma.

AstraZeneca drives innovation in primary care.

Alfasigma Acquires Intercept Pharmaceuticals and Adds Ocaliva to its Portfolio

A provocative work that immerses us in the dark world of denial of scientific evidence and its devastating impact on our society and the environment.

The danger of science denial

Why we should trust scientists

How to separate fact and fiction online